Catalyst Wire Dossier Catalyst Wire Dossier

ERYTHROCIN LACTOBIONATE

ERYTHROMYCIN LACTOBIONATE · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for ERYTHROCIN LACTOBIONATE, covering 2008-02-26 to 2022-11-18. Get the full timeline:

Most recent: FDA Approved: ERYTHROCIN LACTOBIONATE — Supplemental Application (Hospira, Inc.)

See pricing